Maulik Nanavaty, CEO at Anumana
What You Should Know:
– Anumana, an nference portfolio company, announced it has appointed Maulik Nanavaty as chief executive officer (CEO) and member of the Board of Directors.
As CEO, Nanavaty will lead Anumana through a period of growth as the company begins deploying and commercializing its multi-indication ECG-AI platform technology.
– Anumana’s ECG-AI platform represents a breakthrough approach to ECG interpretation, enabling the identification of hidden cardiovascular diseases from standard ECGs at the point of care, for which effective, lifesaving treatments may be available.
Maulik Nanavaty Bio/Background
Nanavaty joins Anumana after 18 years at Boston Scientific, where he served as a senior executive with extensive commercial and operational medical device experience in U.S. and international markets. Murali Aravamudan, co-founder of Anumana and nference, has transitioned to executive chairman of the Anumana Board of Directors while continuing as CEO of nference.
